Numerate company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

numerate.com

Founded Year

2007

Stage

Acquired | Acquired

Total Raised

$19.5M

About Numerate

Numerate is a privately held biotechnology company that applies machine-learning algorithms, at cloud scale, to overcome major challenges in small molecule drug discovery. Numerate's drug design platform combines advances in computer science and statistics with traditional medicinal chemistry approaches to address, in parallel, the factors that determine the success and failure of a drug candidate. Numerate is using this platform to develop a pipeline of drug programs in the cardiovascular, metabolic and neurodegenerative disease areas, focused on targets not typically addressed by computer-aided drug discovery.On September 25, 2020, Numerate was acquired by Valo Health. The terms of the transaction were not disclosed.

Numerate Headquarter Location

1501 Mariposa Street Suite 426

San Francisco, California, 94107,

United States

650-472 0632

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Numerate

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Numerate in 2 CB Insights research briefs, most recently on Jul 12, 2021.

Expert Collections containing Numerate

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Numerate is included in 3 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

8,694 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health

12,795 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

B

Biopharma Tech

838 items

Numerate Patents

Numerate has filed 5 patents.

The 3 most popular patent topics include:

  • Diabetes
  • Diseases of liver
  • G protein coupled receptors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/11/2017

12/15/2020

Diabetes, G protein coupled receptors, Transcription factors, Diseases of liver, Hepatology

Grant

Application Date

9/11/2017

Grant Date

12/15/2020

Title

Related Topics

Diabetes, G protein coupled receptors, Transcription factors, Diseases of liver, Hepatology

Status

Grant

Latest Numerate News

Global AI for Drug Discovery Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025: Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics

Mar 11, 2021

Thursday, 11 Mar 2021 05:19 pm Global AI for Drug Discovery Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025: Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity. By SMN Bureau   Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity. A Latest report published by The Insight Partners named “ AI for Drug Discovery Market ” presents currents and future opportunities, growth scenario, market share and AI for Drug Discovery industry size. The AI for Drug Discovery Report is an excellent source that provides present as well as future analysis of the Industry (both technical & financial) in detail. In addition, the competitive analysis provided in the report gives a superficial idea about the key strategies used by the key players in the market which help them grown their market status. This research study has considered key break downs in the Industry and competing factors which is valuable to take your business to the innovative level. Get Free Sample Brochure (including full TOC, Tables and Figures: https://www.theinsightpartners.com/sample/TIPRE00004177/?source=smartmarketnews-10408 This report can be customized based on the client-specific requirements and stated development. The AI for Drug Discovery Market awareness and growth status are reflected in the report. In-depth insights into the emerging market manufacturers, a SWOT analysis will improve the forecast market growth for profitable business ideas. The AI for Drug Discovery Industry overview, recent developments, manufacturing base, consumption details are scrutinized deeply. Competitive Landscape of Global AI for Drug Discovery Market: Atomwise, Inc. Global AI for Drug Discovery Market Segmentation and Regional Analysis: The AI for Drug Discovery Market share for each type and application is for the year 2020. The revenue share, sales price, upstream raw material suppliers, downstream buyers, and pricing array of AI for Drug Discovery Market is instructed. The dynamic changes in AI for Drug Discovery Industry, technological advancements, mergers & acquisitions are stated. The complete AI for Drug Discovery business profile, products & services overview, geographical presence, import-export details and Market share, gross margin, etc. is summarized in this study. Note: If you have any special requirements, please let us know and we will offer you the report as you want. Global AI for Drug Discovery Market Segment By Region: North America (United States, Canada, Mexico, Europe, Germany, UK, France, Italy, Spain, Russia, Others) Asia-Pacific (China, Japan, South Korea, Australia, India, Southeast Asia, Others) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others) South America (Brazil, Argentina, Columbia, Chile, Others) AI for Drug Discovery report can be divided into following 12 segments Segment 1, states the objectives of AI for Drug Discovery market, review, introduction, product description, growth aspects, and industry presence; Segment 2, elaborates the AI for Drug Discovery market based on key players, their market share, sales volume, company profiles, AI for Drug Discovery competitive market scenario and pricing structure from 2015 to 2019; Segment 3, analyzes the AI for Drug Discovery market at a regional level based on sales ratio and market size from 2015 to 2019; Segment 4, 5, 6 and 7, explains the AI for Drug Discovery market at the country level based on product type, applications, revenue analysis; Segment 8 and 9, states the AI for Drug Discovery industry overview during past, present and forecast period from 2020 to 2026; Segment 10 and 11, describes the market status, plans, expected growth based on regions, type and application in detail for a forecast period of 2020-2026; Segment 12, covers the marketing channels, dealers, manufacturers, trader, distributors, consumers of AI for Drug Discovery. About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense. Contact Us: Email: sales@theinsightpartners.com

  • When was Numerate founded?

    Numerate was founded in 2007.

  • Where is Numerate's headquarters?

    Numerate's headquarters is located at 1501 Mariposa Street, San Francisco.

  • What is Numerate's latest funding round?

    Numerate's latest funding round is Acquired.

  • How much did Numerate raise?

    Numerate raised a total of $19.5M.

  • Who are the investors of Numerate?

    Investors of Numerate include Valo Health, National Heart Lung and Blood Institute, Foundation Capital, Lanza techVentures, Atlas Venture and 3 more.

  • Who are Numerate's competitors?

    Competitors of Numerate include BenevolentAI, Terray Therapeutics, Exscientia, Standigm, Insilico Medicine and 10 more.

You May Also Like

Atomwise Logo
Atomwise

Atomwise uses deep learning neural networks to help discover new medicines. Atomwise achieves results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, start-ups, and research institutions. It is currently using computational drug design to design drugs against COVID.

Insilico Medicine Logo
Insilico Medicine

Insilico Medicine is an artificial intelligence company headquartered in Hong Kong developing a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular structures with specified properties and generate synthetic data.

Cyclica Logo
Cyclica

Cyclica is a global biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights.

GNS Healthcare Logo
GNS Healthcare

GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.

Standigm Logo
Standigm

Standigm is an AI and systems biology-based startup that aims to expedite the drug discovery process. Standigm develops a computer modeling technology that learns medical and biological information and predicts the action mechanism of pharmaceutics in advance. This technology can improve the pharmaceutical development process by tailoring the application of previous know-hows, come up with possible combinations of pharmaceuticals, and optimize the selection of candidates and participants for clinical trials.

Aria Pharmaceuticals Logo
Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company that discovers and develops novel small molecule therapies for complex and hard-to-treat diseases

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.